Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TMEM184B antisense RNA 1 (TMEM184B-AS1) is a long non-coding RNA (lncRNA) mapped to human chromosome 22:38231320-38232248 (hg38). It is transcribed antisense to the TMEM184B gene and is not a protein-coding entity itself. As a non-coding RNA, it is presumed to function in gene expression regulation, but specific roles, associations with diseases, or drug interactions have not been characterized in the available data[1]. Key clarification: TMEM184B-AS1 is distinct from the protein-coding gene TMEM184B. Most molecular and therapeutic interest in "TMEM184B" refers to the protein-encoding gene and its product, not this antisense lncRNA. No evidence currently supports TMEM184B-AS1 as a therapeutic target, disease biomarker, or direct target of drugs[1]. If you intended to refer to TMEM184B (the protein-coding gene), please clarify, as disease associations and molecular classifications differ substantially between these entries.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TMEM184B antisense RNA 1 (TMEM184B-AS1).